Kaye PM - Search Results

1

Post-mortem lung tissue: the fossil record of the pathophysiology and immunopathology of severe COVID-19.

Milross L, Majo J, Cooper N, Kaye PM, Bayraktar O, Filby A, Fisher AJ. Milross L, et al. Among authors: kaye pm. Lancet Respir Med. 2022 Jan;10(1):95-106. doi: 10.1016/S2213-2600(21)00408-2. Epub 2021 Dec 3. Lancet Respir Med. 2022. PMID: 34871544 Free PMC article. Review.

2

Identification of a protein expression signature distinguishing early from organising diffuse alveolar damage in COVID-19 patients.

Ashwin H, Milross L, Wilson J, Majo J, Hang Lee JT, Calder G, Hunter B, James S, Lagos D, Signoret N, Filby A, Bayraktar OA, Fisher AJ, Kaye PM. Ashwin H, et al. Among authors: kaye pm. J Clin Pathol. 2023 Aug;76(8):561-565. doi: 10.1136/jcp-2023-208771. Epub 2023 Mar 9. J Clin Pathol. 2023. PMID: 36894313 Free PMC article.

3

Interferon-γ-Producing CD4⁺ T Cells Drive Monocyte Activation in the Bone Marrow During Experimental Leishmania donovani Infection.

Romano A, Brown N, Ashwin H, Doehl JSP, Hamp J, Osman M, Dey N, Rani GF, Ferreira TR, Kaye PM. Romano A, et al. Among authors: kaye pm. Front Immunol. 2021 Sep 7;12:700501. doi: 10.3389/fimmu.2021.700501. eCollection 2021. Front Immunol. 2021. PMID: 34557190 Free PMC article.

4

Evidence for the involvement of lung-specific gammadelta T cell subsets in local responses to Streptococcus pneumoniae infection.

Kirby AC, Newton DJ, Carding SR, Kaye PM. Kirby AC, et al. Among authors: kaye pm. Eur J Immunol. 2007 Dec;37(12):3404-13. doi: 10.1002/eji.200737216. Eur J Immunol. 2007. PMID: 18022862 Free PMC article.

5

Leishmania donovani infection in scid mice: lack of tissue response and in vivo macrophage activation correlates with failure to trigger natural killer cell-derived gamma interferon production in vitro.

Kaye PM, Bancroft GJ. Kaye PM, et al. Infect Immun. 1992 Oct;60(10):4335-42. doi: 10.1128/iai.60.10.4335-4342.1992. Infect Immun. 1992. PMID: 1398944 Free PMC article.

6

Destruction of follicular dendritic cells during chronic visceral leishmaniasis.

Smelt SC, Engwerda CR, McCrossen M, Kaye PM. Smelt SC, et al. Among authors: kaye pm. J Immunol. 1997 Apr 15;158(8):3813-21. J Immunol. 1997. PMID: 9103448

7

B7-2 blockade enhances T cell responses to Leishmania donovani.

Murphy ML, Engwerda CR, Gorak PM, Kaye PM. Murphy ML, et al. Among authors: kaye pm. J Immunol. 1997 Nov 1;159(9):4460-6. J Immunol. 1997. PMID: 9379045

8

Blockade of CTLA-4 enhances host resistance to the intracellular pathogen, Leishmania donovani.

Murphy ML, Cotterell SE, Gorak PM, Engwerda CR, Kaye PM. Murphy ML, et al. Among authors: kaye pm. J Immunol. 1998 Oct 15;161(8):4153-60. J Immunol. 1998. PMID: 9780188

9

B cell-deficient mice are highly resistant to Leishmania donovani infection, but develop neutrophil-mediated tissue pathology.

Smelt SC, Cotterell SE, Engwerda CR, Kaye PM. Smelt SC, et al. Among authors: kaye pm. J Immunol. 2000 Apr 1;164(7):3681-8. doi: 10.4049/jimmunol.164.7.3681. J Immunol. 2000. PMID: 10725726

10

Immunization with a recombinant stage-regulated surface protein from Leishmania donovani induces protection against visceral leishmaniasis.

Stäger S, Smith DF, Kaye PM. Stäger S, et al. Among authors: kaye pm. J Immunol. 2000 Dec 15;165(12):7064-71. doi: 10.4049/jimmunol.165.12.7064. J Immunol. 2000. PMID: 11120835

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

188 results

Search Page